PER
Click for more information
3.70% 8.4¢ percheron therapeutics limited

Here’s the thingFDA news today approving Sareptas SRP 901 is...

  1. itsagas
    13,066 Posts.
    lightbulb Created with Sketch. 1353
    clock Created with Sketch.
    21/06/24
    16:02
    Post #: 74429232

    Here’s the thing
    FDA news today approving Sareptas SRP 901 is driving the share price up on PER

    why ?
    FDA has set a precedent
    Since we have done a combination study in Exon skipping drugs / we have placed ourselves as a combined useful therapy with Atl1102….
    Also Srp901 will still need Atl1102
    as a matter of fact the whole DMD market will need Atl1102

    PER Price at posting: 8.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.003(3.70%) 		Mkt cap ! $75.73M
Open High Low Value Volume
8.1¢ 8.4¢ 8.1¢ $79.19K 960.1K

Buyers (Bids)

No. Vol. Price($)
1 100200 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 114242 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.